journal article·2017-02

Impact of physicochemical properties of porous silica materials conjugated with dexamethasone via pH-responsive hydrazone bond on drug loading and release behavior

Thanapha Numpilai, Thongthai Witoon, Metta Chareonpanich, Jumras Limtrakul

Publisher page

Abstract

Abstract The conjugation of dexamethasone (DEX) onto modified-porous silica materials via a pH-responsive hydrazone bond has been reported to be highly efficient method to specifically deliver the DEX to diseased sites. However, the influence of physicochemical properties of porous silica materials has not yet been fully understood. In this paper, the impact of pore sizes, particle sizes and silanol contents on surface functionalization, drug loading and release behavior of porous silica materials conjugated with dexamethasone via pH-responsive hydrazone bond was investigated. The grafting density was found to relate to the number of silanol groups on the surface of porous silica materials. The particle size and macropores of the porous silica materials played an vital role on the drug loading and release behavior. Although the porous silica materials with larger particle sizes possessed a lower grafting density, a larger amount of drug loading could be achieved. Moreover, the porous silica materials with larger particle sizes showed a slower release rate of DEX due to a longer distance for cleaved DEX diffusion out of pores. DEX release rate exhibited pH-dependent, sustained release. At pH 4.5, the amount of DEX release within 10 days could be controlled in the range of 12.74–36.41%, depending on the host material. Meanwhile, less than 1.5% of DEX was released from each of type of the porous silica materials at pH 7.4. The results of silica dissolution suggested that the degradation of silica matrix did not significantly affect the release rate of DEX. In addition, the kinetic modeling studies revealed that the DEX releases followed Korsmeyer-Peppas model with a release exponent (n) ranged from 0.3 to 0.47, indicating a diffusion-controlled release mechanism.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. Biological evaluation of isoegomaketone isolated from Perilla frutescens and its synthetic derivatives as anti-inflammatory agents10.1007/s12272-011-0806-8 ↗
2. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats10.1016/j.tox.2006.07.025 ↗
3. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats10.1172/JCI118927 ↗
4. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis10.1186/1471-2474-8-12 ↗
5. Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension10.1097/HJH.0b013e328347da54 ↗
6. Glucocorticoid therapy
7. Synthesis of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis10.1021/bm100578c ↗
8. α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
9. Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure
10. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis10.1002/art.10185 ↗
11. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation10.1038/nm0297-177 ↗
12. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles10.1016/j.biomaterials.2009.09.008 ↗
13. Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery10.1016/j.ijpharm.2010.08.029 ↗
14. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release10.1016/j.colsurfb.2013.06.054 ↗
15. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery10.1016/j.biomaterials.2009.07.020 ↗
16. A macromolecular prodrug strategy for combinatorial drug delivery10.1016/j.jcis.2013.11.061 ↗
17. Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker10.3109/1061186X.2010.504271 ↗
18. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis10.1186/ar2106 ↗
19. Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis10.1007/s11095-008-9683-3 ↗
20. Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity10.1023/A:1016069315423 ↗
21. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles10.1016/j.ijpharm.2006.11.028 ↗
22. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting10.1016/j.ejps.2011.03.001 ↗
23. Impact of pore characteristics of silica materials on loading capacity and release behavior of ibuprofen10.1016/j.msec.2015.09.095 ↗
24. Mechanism for formation of hollow and granular silica aerogel microspheres from rice husk ash for drug delivery10.1016/j.jnoncrysol.2015.09.015 ↗
25. Silica aerogel microparticles from rice husk ash for drug delivery10.1021/ie503867p ↗
26. Influence of pH on cephalexin adsorption onto SBA-15 mesoporoussilica: theoretical and experimental study10.1016/j.apsusc.2014.01.198 ↗
27. Fabrication of SnO2/porous silica/polyethyleneimine nanoparticles for pH-responsive drug delivery10.1016/j.msec.2015.10.032 ↗
28. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics10.1002/anie.201002639 ↗
29. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide10.1016/j.exer.2014.11.002 ↗
30. Siliconmolybdänblau-Verfahren
31. Biodiesel production from transesterification of palm oil with methanol over CaO supported on bimodal meso-macroporous silica catalyst10.1016/j.biortech.2014.01.076 ↗
32. Mesoporous silicon oxycarbide materials for controlled drug delivery systems10.1016/j.cej.2015.05.111 ↗
33. Investigation of bioactivity, biocompatibility and thermal behavior of sol-gel silica glass containing a high PEG percentage10.1016/j.msec.2015.11.077 ↗
34. Biological influence of Ca/P ratio on calcium phosphate coatings by sol-gel processing10.1016/j.msec.2016.03.110 ↗
35. Fabrication of keratin-silica hydrogel for biomedical applications10.1016/j.msec.2016.04.067 ↗
36. Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release10.1016/j.jssc.2011.03.005 ↗
37. Synthesis and characterization of new injectable and degradable dextran-based hydrogels10.1016/j.polymer.2005.07.089 ↗
38. Functionalized mesoporous materials for adsorption and release of different drug molecules: a comparative study10.1016/j.jssc.2009.03.034 ↗
39. Control of hydroxyl group content in silica particle synthesized by the sol-precipitation process10.1016/j.ceramint.2008.04.011 ↗
40. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions10.1021/la051167e ↗
41. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan10.1016/j.jconrel.2010.04.029 ↗
42. Hydrolytic stability of hydrazones and oximes10.1002/anie.200802651 ↗
43. Bis-aliphatic hydrazone-linked hydrogels form most rapidly at physiological pH: identifying the origin of hydrogel properties with small molecule kinetic studies10.1021/cm5007789 ↗
44. Synthesis, characterization and kinetic release profile of iron containing polymeric co-conjugates with antiproliferative activity10.1007/s10904-013-9968-9 ↗
45. Controlled delivery of acyclovir from porous silicon micro-andnanoparticles10.1016/j.apsusc.2015.01.053 ↗
46. Development and in vitro evaluation of acyclovir delivery system using nanostructured porous silicon carriers10.1016/j.cherd.2015.09.008 ↗
47. Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates10.1016/S0960-894X(02)01002-8 ↗